Analysis of sentinel node positivity in primary cutaneous melanoma: an 8-year single institution experience

Overview of attention for article published in Irish Journal of Medical Science, January 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#19 of 1,522)
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 9 news stories from 9 outlets.

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today…

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today…

Study shows the DecisionDx-Melanoma test identifies more patients who can safely forego SLNB than using current guidelines…

- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 5 additional news stories.